625
Participants
Start Date
May 31, 2014
Primary Completion Date
January 20, 2017
Study Completion Date
February 3, 2017
Ondansetron
Eligible children will receive one weight based (0.13 - 0.26 mg/kg) dose of an oral ondansetron disintegrating tablet. Subsequent therapy will be in accordance with World Health Organization guidelines as dictated by the child's hydration status.
Placebo
Eligible children will receive one dose of an oral disintegrating Placebo (sugar pill) tablet. Subsequent therapy will be in accordance with World Health Organization guidelines as dictated by the child's hydration status.
Aga Khan University Hospital, Karachi
Aga Khan Hospital for Women and Children (AKHWC), Kharadar, Karachi
Thrasher Research Fund
OTHER
Bill and Melinda Gates Foundation
OTHER
Aga Khan University
OTHER
Dr. Stephen Freedman
OTHER